4 completed. 4 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 3 | 1 | Completed 1 |
Follow Proctitis: new trials by email Literature Review of Proctitis trials Research Report on Proctitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Budesonide vs. Mesalazine vs. Budesonide/Mesalazine Suppository Combination Therapy in Acute Ulcerative Proctitis Budesonide 2 mg suppository, Budesonide 4 mg suppository, Mesalazine 1 g suppository - Proctitis | Phase 2 | Completed | Dr. Falk Pharma GmbH | 320 | 2013-09-01 | 2019-05-07 |
| Assessment of Photopill Capsule Treatment for Safety and Feasibility in Ulcerative Proctitis Photopill treatment - Ulcerative Colitis, Proctitis | Phase 2 | Completed | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 8 | 2013-01-01 | 2015-06-23 |
| Efficacy of Symbiotic in the Reduction of Acute Radiation Proctitis Symptoms Symbiotic, Maltodextrin - Radiation Proctitis, Prostate Cancer | Phase 2 / Phase 3 | Completed | Federal University of Mato Grosso | 20 | 2012-01-01 | 2013-07-17 |
| Safety, Tolerability, Efficacy Study of PUR 0110 Rectal Enema in Mild-to-Moderate Distal Ulcerative Colitis PUR 0110 Rectal Enema 250 mg, PUR 0110 Rectal Enema 500 mg, PUR 0110 Rectal Enema 1000 mg - Left-Sided Ulcerative Colitis, Proctosigmoiditis | Phase 2 | Completed | PurGenesis Technologies Inc. | 34 | 2010-06-01 | 2018-05-01 |
Colitis, Ulcerative (1) · Lymphoma, Follicular (1) · Proctocolitis (1) · Prostatic Neoplasms (1)
Digestive System Diseases (4) · Gastroenteritis (4) · Gastrointestinal Diseases (4) · Intestinal Diseases (4) · Rectal Diseases (4) · Colitis (2) · Colonic Diseases (2) · Neoplasms (2) · Genital Diseases (1) · Genital Diseases, Male (1) · Genital Neoplasms, Male (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Inflammatory Bowel Diseases (1)
Budesonide (1) · Mesalamine (1) · Suppositories (1) · maltodextrin (1)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Dr. Falk Pharma GmbH (1) · Federal University of Mato Grosso (1) · PurGenesis Technologies Inc. (1)
Germany (2) · Netherlands (1)
Britta Siegmund, Professor (1) · Geert R D'Haens, MD (1) · Theophilus J Gana, MD, PhD (1) · Wolfgang Kruis, Professor (1)
2009 (1)